Epigen Biosciences (United States)
- Research works
- 51 ▼ 77% vs 2013–17
- Citations
- 3.6k 70.5 per fractional work
- Top-10% rate
- 2.4% record average 16.5%
- Open access
- 43% world 28%
Not ranked overall: Epigen Biosciences (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Epigen Biosciences (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, Genomic Integration, Anti-inflammatory, AAV, Viral Vectors, Antioxidant, Anticancer and Biopharmaceutical Production.
- Genome Engineering
- Natural Products
- Stress
- Medicinal Plants
- Baicalein
- Cancer Prevention
- Antioxidants
- Hemophilia
- Biological Activities
- Neuronal Plasticity
- CAR T Cells
- Cancer Immunotherapy
- Depression
- Inflammation
- Recombinant Protein
- Flavonoids
- Biopharmaceutical Production
- Antioxidant
- AAV
- Anti-inflammatory
- Gene Therapy
- Genomic Integration
- Viral Vectors
- Anticancer
- Pharmacology
- Mammalian Cells
- Cancer
- Pharmacokinetics
- Neuroprotective
- Immunotherapy
- Chimeric Antigen Receptor
- Apoptosis
- Factor VIII
- Neuroinflammation
- Antiviral
- Apigenin
- Chronic Pain
- Phytochemistry
- Apoptosis Induction
- Traditional Medicine
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Gene Therapy9▲ 66×3 topics
- Anti-inflammatory6▲ 45×9 topics
- Genomic Integration6▲ 123×2 topics
- AAV6▲ 183×1 topic
- Viral Vectors6▲ 183×1 topic
- Antioxidant4▲ 11×8 topics
- Anticancer4▲ 38×4 topics
- Biopharmaceutical Production4▲ 94×2 topics
- Pharmacology4▲ 21×7 topics
- Flavonoids3▲ 27×4 topics
- Mammalian Cells3▲ 165×1 topic
- Recombinant Protein3▲ 165×1 topic
- Cancer3▲ 4.3×11 topics
- Inflammation3▲ 2.6×13 topics
- Pharmacokinetics3▲ 21×5 topics
- Depression3▲ 6.7×4 topics
- Neuroprotective3▲ 42×2 topics
- Cancer Immunotherapy2▲ 32×2 topics
- Immunotherapy2▲ 7.0×2 topics
- CAR T Cells2▲ 97×1 topic
- Chimeric Antigen Receptor2▲ 97×1 topic
- Neuronal Plasticity2▲ 50×2 topics
- Apoptosis2▲ 8.8×5 topics
- Biological Activities2▲ 18×2 topics
- Factor VIII2▲ 200×1 topic
- Hemophilia2▲ 200×1 topic
- Neuroinflammation2▲ 13×3 topics
- Antioxidants2▲ 7.6×2 topics
- Antiviral2▲ 35×2 topics
- Cancer Prevention2▲ 13×3 topics
- Apigenin2▲ 310×1 topic
- Baicalein2▲ 310×1 topic
- Chronic Pain1▲ 12×2 topics
- Medicinal Plants1▲ 7.6×3 topics
- Phytochemistry1▲ 22×3 topics
- Stress1▲ 6.6×2 topics
- Apoptosis Induction1▲ 49×2 topics
- Natural Products1▲ 15×2 topics
- Traditional Medicine1▲ 25×2 topics
- Genome Engineering1▲ 42×1 topic
Which research topics does Epigen Biosciences (United States) publish most on?
By volume in 2022–2025: Metabolomics and Mass Spectrometry Studies, Diabetes Treatment and Management, Anesthesia and Pain Management and Anesthesia and Sedative Agents.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Metabolomics and Mass Spectrometry Studies Molecular Biology 0 works
- 2 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
- 3 Anesthesia and Pain Management Surgery 0 works
- 4 Anesthesia and Sedative Agents Anesthesiology and Pain Medicine 0 works
- 5 Liver physiology and pathology Hepatology 0 works
- 6 Analytical Chemistry and Chromatography Spectroscopy 0 works
- 7 Liver Disease Diagnosis and Treatment Epidemiology 0 works
- 8 Sphingolipid Metabolism and Signaling Molecular Biology 0 works
- 9 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 0 works
- 10 Chronic Kidney Disease and Diabetes Nephrology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Epigen Biosciences (United States)'s research output changed?
Output in 2018–2022 was 77% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Diego
- University of California San Diego
- San Diego State University
- Scripps Research Institute
- University of San Diego
- University of California San Diego Medical Center
- General Atomics (United States)
- Scripps Health
- Naval Medical Center San Diego
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.